These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 16555967)

  • 1. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal carcinogenicity studies: 1. Poor human predictivity.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):19-27. PubMed ID: 16522147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal carcinogenicity studies: 2. Obstacles to extrapolation of data to humans.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):29-38. PubMed ID: 16522148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
    Wells MY; Williams ES
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
    Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
    Wang NC; Venkatapathy R; Bruce RM; Moudgal C
    Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mouse liver tumor data in risk assessments performed by the U.S. Environmental Protection Agency.
    Beal DD
    Prog Clin Biol Res; 1990; 331():5-18. PubMed ID: 2179964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
    Waters M; Jackson M
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The weight of the evidence among group C carcinogens.
    Engler R; Rinde E; Frick C; Quest J
    Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleged misconceptions' distort perceptions of environmental cancer risks.
    Tomatis L; Melnick RL; Haseman J; Barrett JC; Huff J
    FASEB J; 2001 Jan; 15(1):195-203. PubMed ID: 11149907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.